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Abstract
Background & objectives: The study was designed: (i) to determine the prevalence of malaria
parasites; (ii) to determine the relationship between parasitaemia and age/sex; (iii) to correlate the
PCV levels with parasitaemia; and (iv) to determine the influence of protection against natural
transmission on the prevalence of malaria.
Methods: Participants were recruited at the Plateau State Human Virology Research Laboratory
(PLASVIREC), Robert Gallo House at the Plateau State Specialist Hospital, Jos and grouped into:
(i) Malaria and HIV co-infection group (n = 64); and  (ii) HIV infected group without concurrent
malaria infection (n = 136). Standard laboratory procedures were used for the HIV and Plasmodium
parasites screening, malaria parasite density, and packed cell volume.
Results: The results showed a significant difference (p <0.05) among the sexes and age groups.
About  64 (32%) of the individuals had Plasmodium infection (30% Plasmodium falciparum,
0.5%  P. malariae, and 1.5% mixed infections of P. falciparum and P. malariae). Malaria parasites
were more common among the rural dwellers and in the age group of 21–30 yr. Regression analysis
showed a negative association of malaria parasitaemia and PCV among the malaria–HIV positive
and malaria-HIV negative (r2 = 0.529; p <0.001).
Interpretation & conclusion: In the present study, PCV might be of useful indicator and if not
monitored could lead to AIDS establishment especially where high malaria parasitaemia is noted.
The findings further suggest that the defined stage of HIV infection in the study, malaria co-
infection may moderate the impact of HIV infection on PCV.
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Introduction
Two of the greatest challenges facing Africa today are
human immunodeficiency virus (HIV) infection and
malaria, yet the interaction between these two para-
sitic infections has been little studied. An interaction
between HIV infection and malaria could work in
either direction, i.e. HIV infection might reduce im-
munity to clinical malaria resulting in more frequent
infection among the semi-immune and non-immune,
or malaria might enhance the progression of HIV in-
fection to clinical AIDS1. Sub-Saharan Africa has
>70% of the over 42 million persons infected with
HIV/AIDS worldwide and it is now the leading cause
of death in the region. Nigeria, the most populous
country in Africa, has over four million persons liv-
ing with HIV/AIDS and a national seroprevalence of
5.8% (the end of 2001)2, with the north-central region
harbouring the highest HIV infection levels in the
country3.
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stimulator of the immune system and the subjects ex-
posed frequently to malaria have enhanced serum lev-
els of immunoglobulins and an accelerated rate of IgG
turnover. Other authors7,8 also reported that malaria
infection might have an adverse effect on HIV infec-
tion both by stimulating T-cell turnover and by im-
pairing T-cell cytotoxic function.
Malaria parasitaemia differs in instances of  asymp-
tomatic and clinical malaria, and the degree of
parasitaemia may influence the pathological and bio-
chemical presentations of individuals presenting with
either of these conditions9–13. Reports have shown
that in clinical cases of malaria, anaemia is a promi-
nent factor14,15, which is possibly caused by destruc-
tion of  infected blood cells by the reticuloendothelial
system and haemolysis of infected cells16,17.
The present study was designed: (i) to determine the
prevalence of malaria parasites in HIV/AIDS patients;
(ii) to determine (if any) the relationship between
parasitemia and age/sex; (iii) to correlate the packed
cell volume (PCV) levels with parasitaemia; and  (iv)
to determine the influence of protection against natu-
ral transmission on the prevalence of malaria.
Material & Methods
Study area: The study was conducted at the Plateau
State Human Virology Research Laboratory
(PLASVIREC), Robert Gallo House, at the Plateau
State Specialist Hospital, Jos (located at latitude
9° 55’ to 10°N and longitude 8°52’ to 9°E) from Sep-
tember–November 2006. The area has two seasons,
the dry season (November–March) and the rainy sea-
son (April–October). Malaria transmission is usually
intense as the end of the rainy season approaches.
Other geographical indices of the area have also been
reported elsewhere18.
Ethical clearance: The committee for ethical clear-
ance of the Plateau State Specialist Hospital, Jos ap-
proved the study (Ref. PSSH/ADM/454/IX).
Informed consent was obtained from all study partici-
pants according to the guidelines of the Plateau State
Specialist Hospital, Jos, Plateau State, Nigeria.
Subject selection and sample collection: The study
population was 200 patients confirmed to be HIV-se-
ropositive by standard laboratory techniques and in
addition, presenting clinical signs and symptoms of
malaria. HIV patients who had no malarial parasite,
served as control. PCV of 20 healthy volunteers  were
used as the normal range values.
The following criteria were used for the selection of
the study participants: (i) patients must have not re-
ceived any antimalaria drugs for past two-months
period; (ii) patients must have clinical signs of malaria;
(iii) patients must not be <10 yr and >50 yr of age; (iv)
patients must have been screened as positive for HIV
using HIV1/2 STAT-PAKTM (Manufactured by
CHEMBIO 3661 Horseblock Road, NY, USA) and
further confirmed by Determine HIV1/2 (Abbott Labo-
ratory, Minato-Ku, Tokyo, Japan); and (v) patients
must have been screened  and found not to have Hepa-
titis-B or any previous history of liver disease. The
patients’ age, sex, and occupation were also obtained.
A 5 ml blood sample was obtained by vene-puncture
from each of these patients into an ethylene diamine
tetra-acetic acid (EDTA) anticoagulant bottles.
Examination of samples: Thick and thin films were
prepared from each subject’s blood sample. The thin
films were fixed with absolute methanol and both
thick and thin films were stained with Giemsa after
which they were examined microscopically with oil
immersion under x 100 objective. The parasite count-
ing was done using the thick blood films while the thin
blood films were used for Plasmodium species iden-
tification.  Malaria parasites were counted according
to the method described above19–22. The parasite
count in relation to the leucocytes count were con-
verted to parasite per microliter of blood using the
following mathematical formula.
Number of asexual parasites x 8000
Parasitaemia (l-1) =
Number of leucocytes
Where, 8000 = Putative mean number of leucocytes/
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The number of parasites was counted against 200
leucocytes and expressed as number of parasites/l
blood. The PCV was determined by micro-
haematocrit centrifugation (at a speed of 1200 g for
5 min) of EDTA-whole blood collected into a
capillary tube (Marienfield City, Germany). The
volume of the PCV red cells was measured in a micro-
haematocrit reader as a relative mass of packed red
cells present in a sample of whole blood (percent).
Statistical analysis: All data were statistically
analysed using chi-square, regression, and t- test for
comparison between the infected and uninfected sub-
jects.
Results
Prevalence of malaria parasites with respect to sex
and age is as shown in Table 1 and 64 (32%) of the
200 patients examined had malaria parasites. Of the
64 infected individuals, there were 41 (37.96%) fe-
males and 23 (25%) males. The age group of 21–30
yr was recorded with highest percentage of malaria
infection 35 (17.5%). A significant difference oc-
curred among the sexes (2 =3.84; df = 1; p <0.05)
Table 1. Prevalence of  malaria with respect to
sex and age
Parameter No. No. p-value
examined (%) with malaria
infection (%)
Sex
Male 92 (46) 23 (25)
Female 108 (54) 41 (37.96) <0.05
Total 200 (100) 64 (32)
Age (yr)
<20 30 (15) 11 (5.5)
21–30 82 (41) 35 (17.5)
31–40 46 (23) 12 (6)
41–50 22 (11) 2 (1)
>50 20 (10) 4 (2) <0.05
Total 200 (100) 64 (2)
Age grouping: (2 =12.18; df = 4; p <0.05); Sex: (2 = 3.84;
df = 1; p <0.05).
Table 2. Prevalence of malaria with respect to
occupation
Occupation No. No.
examined  (%)  positive  (%)
Commercial sex 30 (15) 7 (3.5)
   workers (CSW)
Civil servants 60 (30) 17 (8.5)
Farmers 78 (39) 30 (15)
Others (Students) 32 (16) 10 (5)
Total 200 (100) 64 (32)
and between the age groups (2 =12.18; df = 4;
p < 0.05). The highest prevalence rate 30 (15%) of
malaria parasites with respect to occupation was
among the farmers who are mostly rural dwellers
while the lowest was among the commercial sex
workers (Table 2).
Regarding the parasite density (Table 3), 13 (20.31%)
of those with parasite density >5000 l-1 are females
while only 4 (6.25%) are males. Eleven (17.19%) of
the age group 21–30 yr had parasite density >5000
l-1, while 1 (1.56%) in the age group >50 yr had
>5000 l-1. Statistical analysis showed that there was
no significant difference among the sexes (2= 2.71;
df = 1; p >0.05) and age groupings (2=5.38; df=4;
p >0.05). Collective parasite density of the infected
patients was 228.24 x 103 l-1. Of this density, the age
group of 21–30 yr had the highest with 135.92 x 103
l-1 (59.55%), while the least was in the age group 41–
50 yr with 1.4 x 103 l-1 (0.61%) (Table 4).
The regression plot is shown in Fig.1 and  the PCV
level was observed to be closely associated with the
presence of malaria parasitaemia (y =30.935–0.002x;
r2=0.529;   p <0.001). A significant difference
(p <0.05) was observed between the infected and
uninfected as shown on Table 5. The mean total PCV
for the infected was 24.81% and uninfected 34.81%.
Discussion
Malaria infection among the age grouping and vari- J  VECTOR  BORNE  DIS  46, SEPTEMBER 2009 208
Table 3. Levels of parasitaemia with respect to sex and age grouping
Parameters                                            Distribution: Parasite densities (parasite/l-1)
<1000 1000–5000     >5000 Total
Sex
Male 13 (20.31) 6 (9.38) 4 (6.25) 23 (35.94)
Female 17 (26.56) 11 (17.19) 13 (20.31) 41 (64.06)
Total 30 (46.88) 17 (26.56) 17 (26.56) 64 (100)
Age(yr)
 20 5 (7.81) 3 (4.69) 3 (4.69) 11 (17.19)
21–30 14 (21.88) 10 (15.62) 11 (17.19) 35 (54.69)
31–40 6 (9.38) 4 (6.25) 2 (3.12) 12 (18.75)
41–50 2 (3.25) 0 (0) 0 (0) 2 (3.13)
>50 3 (4.69) 0 (0) 1 (1.56) 4 (6.25)
Total 30 (46.88) 17 (26.56) 17 (26.56) 64 (100)
Age grouping  (2 = 5.38; df = 4; p >0.05); Sex: (2 = 2.71; df =1; p >0.05).
Table 4. Parasite density index of patients with respect to sex and age
Age (yr) Distribution: Parasite density (parasite/l) Total
<1000 1000–5000 >5000
Males Females Males Females Males Females
10–20 1.92 x 103 1.88 x 103 5 x 103 10 x 103 18 x 103 6.4 x 103 43.2 x 103
21–30 4.56 x 103 7.76 x 103 11.2 x 103 21.2 x 103 0  x 103 91.2 x 103 135.92 x 103
31–40 2.72 x 103 2.36 x 103 14.92 x 103 0 x 103 5.2 x 103 15 x 103 40.2 x 103
41–50 1.4 x 103 0 x 103 0 x 103 0 x 103 0 x 103 0 x 103 1.4 x 103
>50 1.36 x 103 0.96 x 103 0 x 103 0 x 103 0 x 103 5.2 x 103 7.52 x 103
Total 11.96 x 103 12.96 x 103 31.12 x 103 21.2 x 103 23.2 x 103 117.8 x 103 228.24 x 103
Content Levene’s test for t-test for equality of means
equality of variances
t df Signifi- Mean Standard  95% confidence interval
  F Significance cance (2- differ- error of the difference
tailed) ence difference Lower Upper
Equal variances assumed 9.764 0.002 –11.178 198 0 –9.99632 0.89425 –11.75979 –8.23285
Equal variances not assumed    –9.821 92.183 0 –9.99632 1.01786 –12.01783 –7.97481
 Table 5. t-test for infected and non-infected subjects’ PCV result
Group statistics
Content Status N Mean Standard Standard
deviation error mean
Infected 64 24.8125 7.36115 0.92014
Non-infected 136 34.8088 5.07501 0.43518
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ous sexes was of significant value (p <0.05). Females
were found to be more infected with malaria as com-
pared to their male counterparts. This could be as a
result of cooking at late evenings which are common
in Plateau state and as such they were exposed to
more mosquito bites resulting in the high transmis-
sion. Also, among the various age groups it was re-
vealed that the age group of 21–30 yr had more of
malaria parasitic infection than the other age groups
and this was also confirmed with the high cumulative
density index. This agrees with earlier report from
Tanzania23,24 and from Congo25,26 in HIV-negative
individuals that malaria infection prevalence’s are in-
versely related to age; thus, those between the ages
of 21–30 yr in our study had higher malaria infection
while the older ones are at lower risk. Studies from
Cameroon14,15 both reported in HIV-negative indi-
viduals that young children presenting with severe
malaria parasitaemia have shown to present with PCV
as low as 25%.
The study also showed farmers who are mostly rural
dwellers had the highest infection rate of Plasmodium
infection. This could be attributed to their consistent
bite by mosquitoes and the lack of insecticide treated
nets to curb the menace. With such an intertwined
infection, an intense decrease in PCV could therefore
be envisaged. This confirms the earlier report27 that
rural areas have environmental conditions more
favourable to transmission of the disease than urban
areas; as malaria was found to be more prevalent
among pregnant women from rural areas and they
were at 5.18 times at greater risk than those from
urban areas.
In association of malaria parasitaemia and PCV, the
study revealed a close association which resulted in
the decrease in the PCV of those infected with ma-
laria as compared to those who were only HIV-posi-
tive. The mean total of PCV of the malaria infected
patients was 24.81% and uninfected ones was
34.81% which falls below the normal lower limits of
36–38%28. Packed cell volume of less than 33% has
been reported29, and also PCV of <25% has been as-
sociated with severe malaria infection in children15.
The observation that malaria patients near signifi-
cantly lower PCV levels compared to the control
confirm the earlier reports of a study among HIV-
negative individuals30,31. In some studies on malaria
infection in non-HIV pregnant women by32,27; they
both reported that strong negative association be-
tween malaria parasites density and PCV exists in
these subjects. But the report of Onyenekwe et al33
stated that PCV was not significantly different be-
tween the malaria-HIV co-infected group and HIV
infected group, which is at variance with the results
Regression summary—PCV vs Parasitaemia
Count: 64; No. missing: 0; r: 0.727; r2: 0.529; Adjusted r2:
0.521; RMS residual: 5.094.
ANOVA table—PCV vs Parasitaemia
DF Sum Mean F-value p-value
of squares square
Regression 1 1804.745 1804.745 69.542 <0.0001
Residual 62 1609.005 25.952
Total 63 3413.750
Coefficient Std. Std. t-value p-value
error coeff.
Intercept 30.935 0.972 30.935 31.831 <0.0001
Parasitaemia – 0.002 2.072E-4 – 0.727 – 8.339 <0.0001
Regression  coefficients—PCV vs Parasitaemia
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Fig. 1: Regression plot for parasitaemia and PCV J  VECTOR  BORNE  DIS  46, SEPTEMBER 2009 210
of our study. This could be expected because while
Onyenekwe et al33 worked purely among urban
dwellers in southeastern Nigeria who would have been
exposed to anti-retroviral drugs, good balanced diet
and so on, our studies involved those from both rural
and urban areas who have or have not been on good
balanced diet and so on.
The finding, therefore, suggests that at the defined
stage of HIV infection, malaria co-infection may
moderate the impact of HIV infection on PCV.
Malaria infection in HIV infected subjects in endemic
area may therefore be implicated as contributing to
adverse effect on PCV in HIV co-infected subjects
and could therefore be useful guide in designing
insecticide treated net (ITN) programme for HIV/
AIDS patients.
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